Pricing

Praxis Precision Medicines, Inc. (PRAX)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Marcio Souza
Employees: 110
Web site: praxismedicines.com
99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
617-300-8460
Stock Split History
DateRatio
2023-11-29 1:15
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available